Skip to content

Individualized medication of remimazolam and its influencing factors under total intravenous anesthesia

Individualized medication of remimazolam and its influencing factors under total intravenous anesthesia

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074375
Enrollment
Unknown
Registered
2023-08-04
Start date
2022-06-02
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia

Interventions

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. patients = 18 years of age who are undergoing first-time nail surgery. 2. patients who are capable of complying with the study protocol 3. patients who voluntarily participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with central nervous system disorders, difficult airways and acute upper respiratory tract infections 2. Patients with a history of sedation, antidepressants, anti-anxiety medication, drug or alcohol dependence 3. Patients with severe visual or hearing impairment, mental illness or who for other reasons are unable or refuse to communicate with the visitor 4. a clear history of allergy to benzodiazepines with inadequate preoperative test results 5. those who are participating in other clinical trials 6. other reasons deemed by the investigator to be inappropriate for the clinical trial.

Design outcomes

Primary

MeasureTime frame
Onset time of anesthesia;Duration of anesthesia;

Countries

China

Contacts

Public ContactZhongxing WANG

the First Affiliated Hospital of Sun Yat-sen University

doctorwzx@126.com+86 136 0004 9116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026